SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that ...

Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), ...

A new study shows that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment ...

Phase 3 study met primary and most key secondary clinical endpoints This marks the third developmental and epileptic encephalopathies (DEE) population for fenfluramine ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...

Manchester’s inward investment agency MIDAS has launched a new life sciences prospectus showcasing the city-region's strength in the sector. Business leaders also hailed ...

The biotech sector remains one of the most dynamic areas of the market, driven by clinical breakthroughs, regulatory ...

Data science and AI continue to make healthcare headlines because of their potential to change everything from how drugs are developed to revolutionizing information workflows. One area where we ...

Two UBC Southern Medical Program (SMP) graduates are helping change how cancer survivors receive follow-up care in rural BC, ...

Dr. Brad Nelson has been named B.C. Cancer Victoria’s Lynda and Murray Farmer Immunotherapy Research Chair, which means he ...

Phase 3 Top Line Results Expected Q2 2026 SALT LAKE CITY, June 26, 2025 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its ...